bisbenzimidazole has been researched along with Prostatic Hyperplasia in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afriyie, DK | 1 |
| Asare, GA | 1 |
| Bugyei, K | 1 |
| Lin, J | 1 |
| Peng, J | 1 |
| Hong, Z | 1 |
1 other study available for bisbenzimidazole and Prostatic Hyperplasia
| Article | Year |
|---|---|
Mitochondria-dependent apoptogenic activity of the aqueous root extract of Croton membranaceus against human BPH-1 cells.
Topics: Apoptosis; Bisbenzimidazole; Cell Cycle; Cell Line, Tumor; Cell Nucleus Shape; Cell Proliferation; C | 2015 |